Serum Institute of India founder to set aside 60,000 coronavirus vaccine doses for Parsis

on
Serum Institute of India, which is manufacturing the coronavirus vaccine developed by Oxford University and AstraZeneca, will keep aside 60,000 doses of COVID-19 vaccine for Parsis. Serum Institute founder Cyrus Poonawalla, who is himself a Parsi has decided to set aside the doses of the under-trial vaccine. 

from IndiaTV India: Google News Feed https://ift.tt/3f02Yit

Comments

Post a Comment